Company / Named in our posts
ESSA.
Follow ESSAESSA Pharma Inc. is a pharmaceutical company previously focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer.[1]
01Deal
Deals on Carrywatch
Every deal that names ESSA, and its role in each.
XenoTherapeutics / ESSA
XenoTherapeutics completes acquisition of ESSA Pharma
See deal detailsDeal Web
ESSA and 1 firm it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 25 Oct 2026.
- 01ESSA Announces Completion of Arrangement with XenoTherapeutics
U.S. Securities and Exchange Commission · Researched 25 Oct 2026
Deal posts naming ESSA:
- P01